MILLER RICHARD A MD
SEC insider (Form 3/4/5 filer). CIK 0001031847. President and CEO at Corvus Pharmaceuticals, Inc. (CRVS). 5 reported Form 4/5 transactions since Sep 2024; latest on May 18, 2026. Located in BURLINGAME, CA.
Companies MILLER RICHARD A MD has filed insider reports for
- Corvus Pharmaceuticals, Inc. (CRVS): Director, Officer, President and CEO
MILLER RICHARD A MD
CIK: 0001031847
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Corvus Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 18, 2026CRVS
Corvus Pharmaceuticals, Inc.
PurchaseIndirect5K shares at avg. $12.05$60K - May 18, 2026CRVS
Corvus Pharmaceuticals, Inc.
PurchaseIndirect1.9K shares at avg. $12.01$23K - Dec 4, 2025CRVS
Corvus Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
1M shares- - May 7, 2025CRVS
Corvus Pharmaceuticals, Inc.
ExerciseDirect559.1K shares at avg. $3.50$2.0M - Dec 20, 2024CRVS
Corvus Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
750K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 18, 2026 | CRVS Corvus Pharmaceuticals, Inc. | Purchase | 5,000 | $12.05 | $60,250 | Indirect |
| May 18, 2026 | CRVS Corvus Pharmaceuticals, Inc. | Purchase | 1,932 | $12.01 | $23,203 | Indirect |
| Dec 4, 2025 | CRVS Corvus Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 1,000,000 | - | - | Direct |
| May 7, 2025 | CRVS Corvus Pharmaceuticals, Inc. | Exercise | 559,073 | $3.50 | $1,956,756 | Direct |
| Dec 20, 2024 | CRVS Corvus Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 750,000 | - | - | Direct |
1-5 of 5 transactions